Berger Financial Group, Inc Lexicon Pharmaceuticals, Inc. Transaction History
Berger Financial Group, Inc
- $1.19 Billion
- Q1 2025
A detailed history of Berger Financial Group, Inc transactions in Lexicon Pharmaceuticals, Inc. stock. As of the latest transaction made, Berger Financial Group, Inc holds 10,929 shares of LXRX stock, worth $7,431. This represents 0.0% of its overall portfolio holdings.
Number of Shares
10,929
Previous 10,929
-0.0%
Holding current value
$7,431
Previous $8,000
37.5%
% of portfolio
0.0%
Previous 0.0%
Shares
1 transactions
Others Institutions Holding LXRX
# of Institutions
134Shares Held
196MCall Options Held
310KPut Options Held
77.3K-
Artal Group S.A. Luxembourg, N4136MShares$92.6 Million100.0% of portfolio
-
Black Rock Inc. New York, NY9.89MShares$6.73 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA9.56MShares$6.5 Million0.0% of portfolio
-
Schonfeld Strategic Advisors LLC New York, NY8.21MShares$5.58 Million0.03% of portfolio
-
Geode Capital Management, LLC Boston, MA3.69MShares$2.51 Million0.0% of portfolio
About LEXICON PHARMACEUTICALS, INC.
- Ticker LXRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 188,726,000
- Market Cap $128M
- Description
- Lexicon Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of pharmaceutical products. Its orally-delivered small molecule drug candidates under development comprise Sotagliflozin that completed Phase III clinical trials for the for the treatment of heart failure and type 1 diabetes; ...